Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This study is researching an experimental drug called linvoseltamab (called "study drug"). The study is focused on participants with newly diagnosed multiple myeloma (NDMM) who are eligible for high dose chemotherapy with autologous stem cell transplantation (transplant-eligible) or ineligible for autologous stem cell transplantation (transplant-ineligible). The aim of this clinical trial is to study the safety, tolerability (how the body reacts to the drug), and effectiveness (tumor shrinkage)
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this multiple myeloma clinical trial in New York, NY
If you're searching for multiple myeloma treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.